Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03944434
Title FACILE: FeAsibility of First-line riboCIclib in oLdEr Patients With Advanced Breast Cancer (FACILE)
Acronym FACILE
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fondazione Sandro Pitigliani
Indications
Therapies
Age Groups: senior
Covered Countries ITA


No variant requirements are available.